Lupin unveils injection for thiamine in US

New Delhi: Pharma major Lupin on Monday said it has launched in the US its generic Thiamine Hydrochloride injection 200 mg/2 mL (100 mg/mL) multiple-dose vials used for treatment of thiamine deficiency. The launch follows alliance partner Caplin Steriles receiving an approval for its ANDA (Abbreviated New Drug Application) from the US Food and Drug Administration (USFDA). The injection is therapeutically equivalent to the reference listed drug Thiamine Hydrochloride Injection 200 mg/2 ml (100mg/mL) of Fresenius Kabi USA LLC.